Wikidata

(Q57612974)

English

Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

scientific article published on 21 August 2011

In more languages

Statements

title
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21859692
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21859692%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57612974&oldid=1977503210"